Invention Grant
- Patent Title: Therapeutic anti-CD9 antibody
-
Application No.: US16068742Application Date: 2017-01-06
-
Publication No.: US11136407B2Publication Date: 2021-10-05
- Inventor: Hergen Spits , Paula Maria Wilhelmina Van Helden , Remko Schotte , Wouter Pos , Christien Fatmawati , Danïel Michiel Go , Koen Wagner , Julien Christian Villaudy
- Applicant: AIMM Therapeutics B.V.
- Applicant Address: NL Amsterdam Zuidoost
- Assignee: AIMM Therapeutics B.V.
- Current Assignee: AIMM Therapeutics B.V.
- Current Assignee Address: NL Amsterdam Zuidoost
- Agency: Verrill Dana, LLP
- Priority: EP16150698 20160108
- International Application: PCT/NL2017/050003 WO 20170106
- International Announcement: WO2017/119811 WO 20170713
- Main IPC: C07K16/28
- IPC: C07K16/28 ; G01N33/574 ; A61P35/00 ; C07K14/705 ; A61K39/00
Abstract:
The present invention provides novel binding compounds and therapeutic applications thereof.
Public/Granted literature
- US20190023803A1 Therapeutic Anti-CD9 Antibody Public/Granted day:2019-01-24
Information query
